about
Mid-range left ventricular ejection fraction: Clinical profile and cause of death in ambulatory patients with chronic heart failure.Phenotype and prognostic correlations of the converter region mutations affecting the β myosin heavy chainCurrent state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.[In-hospital and long-term mortality in women with acute myocardial infarction treated by primary angioplasty].[Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation.Comprehensive clinical evaluation of a large Spanish family with Anderson-Fabry disease, novel GLA mutation and severe cardiac phenotype.Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases.[Cooperative Cardiovascular Disease Research Network (RECAVA)].Somatic MYH7, MYBPC3, TPM1, TNNT2 and TNNI3 mutations in sporadic hypertrophic cardiomyopathy.Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies.Unexpected autopsy findings after sudden cardiac death: cardiovascular myxoedema and endocardial fibroelastosis.Sex-related differences in cardiomyopathiesRelation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathyPrevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathyGadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathyHypertrophic or hypertensive cardiomyopathy?Mutation in JPH2 cause dilated cardiomyopathyHypertrophic cardiomyopathyPhenotypic Characterization of a Family With An In-frame Deletion in the DMD Gene and Variable PenetranceGenetic Factors Involved in Cardiomyopathies and in CancerALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant
P50
Q30572418-B5FFCC06-B446-42E5-8380-D72FA159A5ABQ35792948-FBBA8C95-DFE4-4384-94AF-0A08A12C4036Q38119180-815767C7-9785-4CFC-86F0-57FA53C39F1DQ45215281-4E1D7281-1563-49F0-AA9E-2A27CF9B85D2Q46603098-007D079F-B4F9-4A5C-B1BB-94FA727FDD5AQ50254257-6D13F732-9200-4CB2-AD9C-6B82989306B1Q50475493-8F004C44-7381-40D8-AEAD-809402268DF3Q50499373-358B147A-D1C6-4CF4-BA1F-907587BA890AQ50661493-4190DABC-4ECD-40AA-980A-465AEF8FF325Q50894466-A55075E5-05EE-45FE-8FAB-B2F3C58AA90AQ51291901-B302743F-5314-46EF-A7F8-76A9ED8D9483Q53645069-5A6DD203-C26B-428D-9DBA-9B54C670AC25Q58592286-D4BD0BC0-F8F2-4BDD-B92F-271E451411D8Q73682058-16FA6AD5-5EC5-4F17-9748-C0C7AB0372E5Q80396451-18768993-9C58-4D3E-9B2C-80C667916981Q81750684-7F1EFF9B-F25E-4339-B8D8-444C3DF3A7F7Q86812497-B1550DE3-B9FB-4324-B77E-253328088170Q88019828-6F191EE2-D4DA-44CB-8888-11F4CA91D051Q89304985-2C5B478F-CDCE-45FF-9AAD-0D90CDE0AAB0Q89468941-CF53B6B7-4513-4F71-A320-360B7FD7670DQ96128587-EC3D8FD5-CB37-41C3-8090-88D7B4B9BCB6Q96339244-EB1BAFEA-8EDF-48CF-839C-F7A14DAC0274
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Juan Gimeno Blanes
@ast
Juan Gimeno Blanes
@en
Juan Gimeno Blanes
@es
Juan Gimeno Blanes
@nl
Juan Gimeno Blanes
@sl
type
label
Juan Gimeno Blanes
@ast
Juan Gimeno Blanes
@en
Juan Gimeno Blanes
@es
Juan Gimeno Blanes
@nl
Juan Gimeno Blanes
@sl
prefLabel
Juan Gimeno Blanes
@ast
Juan Gimeno Blanes
@en
Juan Gimeno Blanes
@es
Juan Gimeno Blanes
@nl
Juan Gimeno Blanes
@sl
P1053
I-4269-2015
P106
P1153
7005858968
P21
P31
P3829
P496
0000-0001-5818-1754